Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroblastoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Congenital Abnormalities 1 Blast Crisis 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 24 Vincristine 20 Carboplatin 18 Doxorubicin 15 Etoposide 14 Melphalan 12 Radiotherapy 11 Filgrastim 11 Cisplatin 11 Magnetic Resonance Spectroscopy 10 Isotretinoin 10 Specimen Handling 9 Peripheral Blood Stem Cell Transplantation 9 dinutuximab 8 Biopsy 8 X-Rays 7 Topotecan 7 Temozolomide 7 aldesleukin 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 Busulfan 6 sargramostim 5 Irinotecan 5 Vindesine 4 Neoadjuvant Therapy 4 Ipilimumab 4 Ifosfamide 4 Dacarbazine 4 3-Iodobenzylguanidine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Neuroblastoma × XK 469 × Clear all

NCT00028522 2013-12-16

R(+)XK469 in Treating Patients With Advanced Neuroblastoma

National Cancer Institute (NCI)

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡